Detalhe da pesquisa
1.
Combining targeted DNA repair inhibition and immune-oncology approaches for enhanced tumor control.
Mol Cell
; 83(5): 660-680, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36669489
2.
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions.
CA Cancer J Clin
; 73(6): 620-652, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37329269
3.
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.
Cell
; 158(4): 929-944, 2014 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25109877
4.
Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells.
Mol Cell
; 76(5): 838-851.e5, 2019 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31564558
5.
Author Correction: CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells.
Nature
; 569(7756): E4, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31043737
6.
CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells.
Nature
; 546(7656): 168-172, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28538732
7.
Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer.
Br J Cancer
; 127(3): 569-576, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35440668
8.
DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms.
Oncologist
; 27(11): 940-951, 2022 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35983951
9.
Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC.
J Transl Med
; 20(1): 541, 2022 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36419183
10.
The role of Schlafen 11 (SLFN11) as a predictive biomarker for targeting the DNA damage response.
Br J Cancer
; 124(5): 857-859, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33328609
11.
A wake-up call for cancer DNA damage: the role of Schlafen 11 (SLFN11) across multiple cancers.
Br J Cancer
; 125(10): 1333-1340, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34294893
12.
Evaluation of PARP and PDL-1 as potential therapeutic targets for women with high-grade neuroendocrine carcinomas of the cervix.
Int J Gynecol Cancer
; 30(9): 1303-1307, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32727929
13.
HIRA deficiency in muscle fibers causes hypertrophy and susceptibility to oxidative stress.
J Cell Sci
; 130(15): 2551-2563, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28600325
14.
eIF2ß, a subunit of translation-initiation factor EIF2, is a potential therapeutic target for non-small cell lung cancer.
Cancer Sci
; 109(6): 1843-1852, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29624814
15.
Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: A SEER database analysis of 162,983 cases.
Cancer
; 124(4): 807-815, 2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29211313
16.
Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers.
Br J Cancer
; 118(11): 1419-1424, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29695765
17.
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.
Lancet Oncol
; 18(1): 42-51, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27932068
18.
Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer.
Cancer Sci
; 108(4): 732-743, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28165654
19.
Giving AXL the axe: targeting AXL in human malignancy.
Br J Cancer
; 116(4): 415-423, 2017 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28072762
20.
drexplorer: A tool to explore dose-response relationships and drug-drug interactions.
Bioinformatics
; 31(10): 1692-4, 2015 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25600946